T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity.
BACKGROUND: Synthetic peptides, representing CD4(+) T cell epitopes, derived from the primary sequence of allergen molecules have been used to down-regulate allergic inflammation in sensitised individuals. Treatment of allergic diseases with peptides may offer substantial advantages over treatment w...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2005-03-01
|
| Series: | PLoS Medicine |
| Online Access: | http://europepmc.org/articles/PMC1069669?pdf=render |